France-based industrial biotechnology company Global Bioenergies have successfully raised a final gross value of EUR 23 million resulting in the creation of 927,419 new shares after it launched its capital increase on June 27 when the company decided to fully exercise its extension clause. The company had a subscription rate increase of 143% with a total order for 1.15 million ordinary shares amounting to approximately EUR 28.6 million. French investment funds have largely participated in the operation as well as attracting investors from several other European countries and from the USA.